![](/images/Email.png)
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)